Department of Neurosurgery, Università Politecnica delle Marche, Via Conca 71, 60126, Ancona, Italy.
Neurosurg Rev. 2020 Apr;43(2):695-708. doi: 10.1007/s10143-019-01110-7. Epub 2019 May 8.
Cast intraventricular hemorrhage (IVH) is associated to high morbidity/mortality rates. External ventricular drainage (EVD), the most common treatment adopted in these patients, may be unsuccessful due to short-term drain obstruction and requires weeks for cerebrospinal fluid (CSF) clearing, increasing the risks of ventriculits. Administration of intraventricular fibrinolytic agents and endoscopic evacuation have been proposed as alternative treatments, but with equally poor results. We present a retrospective analysis of two groups of patients who respectively underwent endoscope-assisted microsurgical evacuation versus EVD for the treatment of cast IVH. In a 10-year time, 25 patients with cast IVH underwent microsurgical, endoscope-assisted evacuation. Twenty-seven were instead treated by EVD. The two groups were compared in terms of hematoma evacuation, CSF clearing time, infection rates, need for permanent shunting, short/long-term survival, and functional outcome. In endoscope-assisted surgeries, full CSF clearance required 14 ± 3 days in 20 patients and 21 ± 3 days in 5; in the EVD group, 21 ± 3 days were needed in 12 patients, 28 ± 3 days in 11, and 35 ± 3 days in 4. Permanent shunting was inserted respectively in 19 endoscopic and 23 EVD patients. Final mRs score was 0-3 in 13 endoscopic cases, 4-5 in the remaining 12. In the EVD group, 7 subjects scored mRs 0-3, 16 scored 4-5; 4 died. In our experience, endoscope-assisted evacuation of cast IVH reduced ICU staying and CSF clearance times. It also seemed to improve neurological outcome, but without affecting the need for permanent shunt. On the counterside, it increases the number of severely disabled survivors.
脑室内出血(IVH)与高发病率/死亡率相关。脑室引流(EVD)是这些患者最常采用的治疗方法,但由于短期引流阻塞,可能会失败,并且需要数周时间才能清除脑脊液(CSF),增加了脑室炎的风险。已经提出了脑室内纤溶剂给药和内镜清除作为替代治疗方法,但结果同样不佳。我们对分别接受内镜辅助显微镜下清除术与 EVD 治疗铸型 IVH 的两组患者进行了回顾性分析。在 10 年时间里,25 例铸型 IVH 患者接受了显微镜下内镜辅助清除术。27 例患者接受 EVD 治疗。比较了两组患者的血肿清除、CSF 清除时间、感染率、需要永久性分流、短期/长期存活率和功能结果。在内镜辅助手术中,20 例患者 CSF 完全清除需要 14±3 天,5 例患者需要 21±3 天;在 EVD 组中,12 例患者需要 21±3 天,11 例患者需要 28±3 天,4 例患者需要 35±3 天。分别有 19 例内镜和 23 例 EVD 患者插入了永久性分流管。最终 mRs 评分在 13 例内镜病例中为 0-3,在其余 12 例中为 4-5。在 EVD 组中,7 例患者 mRs 评分 0-3,16 例患者评分 4-5;4 例死亡。根据我们的经验,内镜辅助清除铸型 IVH 可减少 ICU 住院时间和 CSF 清除时间。它似乎还改善了神经功能预后,但并未影响永久性分流的需求。另一方面,它增加了严重残疾幸存者的数量。